| Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients Y Olgun, S Aktaş, Z Altun, G Kırkım, DÇ Kızmazoğlu, AP Erçetin, B Demir, ... International journal of pediatric otorhinolaryngology 90, 64-69, 2016 | 45 | 2016 |
| Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity Y Olgun, G Kırkım, E Kolatan, M Kıray, A Bagrıyanık, A Olgun, ... The Laryngoscope 124 (3), 760-766, 2014 | 40 | 2014 |
| Assessment of health-related quality of life in pediatric acute lymphoblastic leukemia survivors: perceptions of children, siblings, and parents D Kızmazoğlu, S Sarı, ME Sezgin, A Kantarcıoğlu, Ö Tüfekçi, ... Turkish Journal of Hematology 36 (2), 112, 2019 | 38 | 2019 |
| Protective effect of Korean red ginseng on cisplatin ototoxicity: is it effective enough? Y Olgun, G Kırkım, Z Altun, S Aktaş, E Kolatan, M Kiray, A Bağrıyanık, ... Journal of International Advanced Otology 12 (2), 2016 | 19 | 2016 |
| FLAG regimen with or without Idarubicin in children with relapsed/refractory acute leukemia: Experience from a Turkish pediatric hematology center ŞY Bengoa, E Ataseven, D Kızmazoğlu, FD Yenigürbüz, M Erdem, H Ören Turkish Journal of Hematology 34 (1), 46, 2017 | 11 | 2017 |
| Analysis of apoptotic, platelet-derived, endothelial-derived, and tissue factor-positive microparticles of children with acute lymphoblastic leukemia during induction therapy FD Yenigürbüz, D Kizmazoglu, H Ates, M Erdem, Ö Tüfekçi, S Yilmaz, ... Blood Coagulation & Fibrinolysis 30 (4), 149-155, 2019 | 10 | 2019 |
| Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience N Olgun, E Cecen, D Ince, D Kizmazoglu, B Baysal, A Onal, O Ozdogan, ... Frontiers in Oncology 12, 1041443, 2022 | 9 | 2022 |
| Investigation of the relationship between Fok1 and COL1A1 gene polymorphisms and development of treatment-related bone complications in children with acute lymphoblastic leukemia M Erdem, Ö Tüfekçi, S Kızıldağ, Ş Yılmaz, D Kızmazoğlu, BE Filibeli, ... Turkish Journal of Hematology 36 (1), 12, 2019 | 9 | 2019 |
| S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients G Sanlav, B Baran, SK Özşengezer, D Kizmazoğlu, Z Altun, S Aktaş, ... Journal of pediatric hematology/oncology 46 (1), 21-28, 2024 | 1 | 2024 |
| Comparing tribbles homolog 3 (TRIB3) protein expression levels with clinicopathological characteristics and survival among neuroblastoma patients B Baran, G Sanlav, D Kızmazoğlu, S Kum Özşengezer, S Aktaş, Z Altun, ... Clinical Medicine Insights: Oncology 17, 11795549231199926, 2023 | 1 | 2023 |
| Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies T Aktas, D Kizmazoglu, S Aktas, A Erol, E Serinan, O Gokbayrak, ... Frontiers in Bioscience-Landmark 28 (8), 2023 | 1 | 2023 |
| Evaluation of Risk Factors Causing Ototoxicity in Childhood Cancers Located in the Head and Neck Region Treated With Platinum-based Chemotherapy Y Olgun, DÇ Kizmazoğlu, D İnce, H Ellidokuz, EA Güneri, N Olgun, ... Journal of pediatric hematology/oncology 43 (7), e930-e934, 2021 | 1 | 2021 |
| Çocukluk Çağında Tedavi İlişkili Ototoksisiteye Yaklaşım D Kızmazoğlu, Y Olgun, D İnce | 1 | 2019 |
| Infantile Hemangiomas of the Head and Neck: A Single-Center Experience D Kizmazoglu, D Ince, Y Olgun, E Cecen, H Guleryuz, T Erdag, N Olgun Children 11 (3), 311, 2024 | | 2024 |
| Investigation of YAP‐1, OTX‐2, and nestin protein expressions in neuroblastoma: a preliminary study S Kum Özşengezer, ZS Altun, G Sanlav, B Baran, D Kızmazoğlu, S Aktaş, ... Annals of Clinical and Translational Neurology, 2024 | | 2024 |
| Pediatric paravertebral tumors: analysis of 96 patients D Kizmazoglu, D Ince, E Cecen, C Kizmazoglu, H Guleryuz, E Ozer, ... Child's Nervous System 40 (1), 123-133, 2024 | | 2024 |
| Atypical Presentation and Course of ACTH-independent Cushing's Syndrome in Two Families. S Acar, A Paketçi, Ö Kırbıyık, M Erbaş, Ö Besci, A Kağızmanlı, ... Journal of Clinical Research in Pediatric Endocrinology, 2023 | | 2023 |
| Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity TÇ Aktaş, D Kızmazoğlu, S Aktaş, ÖE Gökbayrak, E Serinan, A Erol, ... Technology in Cancer Research & Treatment 22, 15330338231211138, 2023 | | 2023 |
| Development of a new biomarker at the level of gene change in cisplatin ototoxicity D Kızmazoğlu, A Erol, T Aktaş, Y Olgun, A Demir, Z Altun, S Aktaş Pediatric Blood & Cancer, 2023 | | 2023 |
| Onkolojik/Neoplastik Hastalıkların Nörolojik Bulguları D KIZMAZOĞLU, E ÇEÇEN, D İnce Turkiye Klinikleri Pediatric Neurology-Special Topics 4 (3), 71-76, 2023 | | 2023 |
Safiye AktasDokuz Eylul University在 deu.edu.tr 的电子邮件经过验证
